Abstract

PurposeIncreasing evidence suggests a role for macrophages in the pathogenesis of age-related macular degeneration (AMD). This study examined choroidal macrophages and their activation in postmortem eyes from subjects with and without AMD.MethodsChoroids were incubated with anti-ionized calcium-binding adapter molecule 1 (anti-IBA1) to label macrophages, anti-human leukocyte antigen-antigen D-related (anti-HLA-DR) as a macrophage activation marker, and Ulex europaeus agglutinin lectin to label blood vessels. Whole mounts were imaged using confocal microscopy. IBA1- and HLA-DR–positive (activated) cells were counted in submacula, paramacula, and nonmacula, and cell volume and sphericity were determined using computer-assisted image analysis.ResultsIn aged control eyes, the mean number of submacular IBA1+ and HLA-DR+ macrophages was 433/mm2 and 152/mm2, respectively. In early AMD eyes, there was a significant increase in IBA1+ and HLA-DR+ cells in submacula compared to those in controls (P = 0.0015 and P = 0.008, respectively). In eyes with neovascular AMD, there were significantly more HLA-DR+ cells associated with submacular choroidal neovascularization (P = 0.001). Mean cell volume was significantly lower (P ≤ 0.02), and sphericity was significantly higher (P ≤ 0.005) in all AMD groups compared to controls.ConclusionsThe average number of IBA1+ macrophages in submacular and paramacular choroid was significantly higher in early/intermediate AMD compared to that in aged controls. HLA-DR+ submacular macrophages were significantly increased in all stages of AMD, and they were significantly more round and smaller in size in the submacular AMD choroid, suggesting their activation. These findings support the concept that AMD is an inflammatory disease.

Highlights

  • Increasing evidence suggests a role for macrophages in the pathogenesis of agerelated macular degeneration (AMD)

  • In early AMD eyes, there was a significant increase in IBA1þ and HLA-DRþ cells in submacula compared to those in controls (P 1⁄4 0.0015 and P 1⁄4 0.008, respectively)

  • In eyes with neovascular AMD, there were significantly more HLA-DRþ cells associated with submacular choroidal neovascularization (P 1⁄4 0.001)

Read more

Summary

Methods

Choroids were incubated with anti-ionized calcium-binding adapter molecule 1 (anti-IBA1) to label macrophages, anti-human leukocyte antigen-antigen D-related (anti-HLADR) as a macrophage activation marker, and Ulex europaeus agglutinin lectin to label blood vessels. IBA1- and HLA-DR–positive (activated) cells were counted in submacula, paramacula, and nonmacula, and cell volume and sphericity were determined using computer-assisted image analysis. Human donor eyes were obtained from 16 subjects (Table). Eyes were classified according to severity of disease: early AMD, defined as soft indistinct drusen with or without pigmentary changes (CARMS grade 2 [n 1⁄4 2]); intermediate AMD, or soft distinct drusen with pigmentary changes (CARMS grade 3 [n 1⁄4 3]); and late (end-stage) AMD (n 1⁄4 8). Late AMD was classified as dry AMD with GA (characterized by thick basal laminar deposits and distinct areas of RPE loss [CARMS grade 4 {n 1⁄4 5}]) or neovascular disease with CNV (CARMS grade 5 [n 1⁄4 3]). Subjects with a history of diabetes mellitus were excluded from the study

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call